These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 15039808)
21. Activated protein C for severe sepsis. Garces K Issues Emerg Health Technol; 2002 Mar; (30):1-4. PubMed ID: 11985365 [TBL] [Abstract][Full Text] [Related]
22. [Activated protein C, coagulation, inflammation and treatment of severe sepsis]. van Zanten AR; Bakker J; van den Berg PC; Girbes AR; van Leeuwen SJ Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1179. PubMed ID: 11433670 [No Abstract] [Full Text] [Related]
23. Drotrecogin alfa: a role in emergency department treatment of severe sepsis? McLeay AM Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of drotrecogin alfa (activated) for the therapy of surgical patients with severe sepsis. Barie PS; Hydo LJ; Shou J; Eachempati SR Surg Infect (Larchmt); 2006; 7 Suppl 2():S77-80. PubMed ID: 16895513 [TBL] [Abstract][Full Text] [Related]
25. Activated protein C for severe sepsis. Ely EW; Bernard GR; Vincent JL N Engl J Med; 2002 Sep; 347(13):1035-6. PubMed ID: 12324564 [No Abstract] [Full Text] [Related]
26. Risks and benefits of activated protein C treatment for severe sepsis. Warren HS; Suffredini AF; Eichacker PQ; Munford RS N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562 [No Abstract] [Full Text] [Related]
27. [Activated protein C, coagulation, inflammation and treatment of severe sepsis]. Bartelink AK; van Deuren M Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1178-9. PubMed ID: 11433669 [No Abstract] [Full Text] [Related]
28. The role of heparin and allied compounds in the treatment of sepsis. Cornet AD; Smit EG; Beishuizen A; Groeneveld AB Thromb Haemost; 2007 Sep; 98(3):579-86. PubMed ID: 17849046 [TBL] [Abstract][Full Text] [Related]
29. Activated protein C in sepsis: a critical review. Levi M Curr Opin Hematol; 2008 Sep; 15(5):481-6. PubMed ID: 18695371 [TBL] [Abstract][Full Text] [Related]
30. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis]. Bartelink AK Ned Tijdschr Geneeskd; 2006 Feb; 150(7):352-4. PubMed ID: 16523795 [TBL] [Abstract][Full Text] [Related]
31. Drotrecogin alfa: new preparation. For some cases of severe sepsis? Prescrire Int; 2003 Apr; 12(64):55-7. PubMed ID: 12674116 [TBL] [Abstract][Full Text] [Related]
32. Role of activated protein C in the pathophysiology of severe sepsis. Dettenmeier P; Swindell B; Stroud M; Arkins N; Howard A Am J Crit Care; 2003 Nov; 12(6):518-24; quiz 525-6. PubMed ID: 14619357 [TBL] [Abstract][Full Text] [Related]
33. Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery. Pappalardo F; Cristallo E; Franco A; Antonioli G; Zangrillo A Eur J Anaesthesiol; 2007 Mar; 24(3):294-5. PubMed ID: 17054810 [No Abstract] [Full Text] [Related]
34. Assessing the use of activated protein C in the treatment of severe sepsis. Siegel JP N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563 [No Abstract] [Full Text] [Related]
35. Recombinant human activated protein C. Hughes M Int J Antimicrob Agents; 2006 Aug; 28(2):90-4. PubMed ID: 16837170 [TBL] [Abstract][Full Text] [Related]
36. Recombinant activated protein C: decisions for administration. Dellinger RP Crit Care Med; 2006 Feb; 34(2):530-1. PubMed ID: 16424737 [No Abstract] [Full Text] [Related]
37. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis]. Girbes AR; Polderman KH; Beishuizen A; van Zanten AR; Schultz MJ Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1265-6; author reply 1266. PubMed ID: 16796179 [No Abstract] [Full Text] [Related]
38. Breakthrough found in treatment of severe sepsis. Clin Resour Manag; 2001 Jul; 2(7):107-9. PubMed ID: 11482248 [TBL] [Abstract][Full Text] [Related]
39. Protein C and acute inflammation: a clinical and biological perspective. Christiaans SC; Wagener BM; Esmon CT; Pittet JF Am J Physiol Lung Cell Mol Physiol; 2013 Oct; 305(7):L455-66. PubMed ID: 23911436 [TBL] [Abstract][Full Text] [Related]
40. [Treatment of severe sepsis and multiple organ failure with activated protein C]. Strøm JJ Ugeskr Laeger; 2004 Mar; 166(11):995. PubMed ID: 15049233 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]